| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |